August 6, 2015
Hypofractionation vs. Conventional fractionation in breast cancer radiotherapy
IHPI member Reshma Jagsi, M.D., D.Phil., recently had an article published in The Journal of the American Medical Association (JAMA).
Jagsi and coauthors conducted a study that looked at data collected on acute toxic effects and patient-reported outcomes in a group of women treated with varying radiation fractionation in practices collaborating in the Michigan Radiation Oncology Quality Consortium.
The authors analyzed data from 2,309 patients for whom there was a physician toxicity evaluation within one week of completing radiation therapy and at least one weekly toxicity evaluation during treatment.
Found in